China - International Pharmaceutical Industry

News

China sees huge bounce in pharma rankings ahead of hybrid CPhI & P-MEC China

China is the pharma industry's biggest gainer in the 2021 CPhI Annual Rankings, with digital matchmaking driving new waves of partnerships China's pharma industry...

17 November 2021 News China | CPhI Annual Rankings

Continue Reading →

Volume 13 Issue 3

Biotech in China: Maximising the Global Opportunity

Pharmaceutical companies from China are showing an increasing interest in international market opportunities, focusing on new drug developments in the biological fie...

13 September 2021 Volume 13 Issue 3 biological | biotech

Continue Reading →

News

WuXi STA first CDMO to support the approval of an innovative drug in China through the “MAH” pilot

WuXi STA enables Ascletis to receive NDA Approval from China FDA for Ganovo® STA Pharmaceutical Co., Ltd. (WuXi STA), a subsidiary of WuXi AppTec, announces that its...

19 June 2018 News approval | CDMO

Continue Reading →

News

Healios receives rights to develop and commercialize additional indications and Athersys receives $20 million in license fees, plus potential milestones payments and royalties

Discussions extended for China and other rights Athersys, Inc. (NASDAQ:ATHX) announced today that it has entered into an agreement with HEALIOS K.K. ("Healios...

12 June 2018 News China | commercialize

Continue Reading →

News

China’s domestic pharma industry driving huge machinery influx at P-MEC China

45,000 industry experts attend as intelligent manufacturing and new environmental policies identified as key medium term trends P-MEC China will be held at the Shang...

5 June 2018 News China | domestic

Continue Reading →

News

Internationalisation and regulatory reform driving growth and investment at CPhI China

2018 event prepares for surge in international attendees as MAH nears national rollout CPhI & P-MEC China (#CPhIChina) – organized by UBM and UBM SINEXPO – takes...

17 May 2018 News CFDA | China

Continue Reading →

Uncategorised

China eliminates import duties on 28 Indian medicines

China has exempted import tariffs (duties) for 28 drugs, including all cancer drugs, from May 1st China has removed import duties on as many as 28 medicines,...

8 May 2018 Uncategorised China | duties

Continue Reading →

News

6th DPI Dry Powder Technology China Technology Conference

From March 20-23, 2018, the 6th DPI Dry Powder Technology China Technology Conference in Shanghai bringing almost 300 participants from the Chinese pharmaceutical in...

26 March 2018 News China | conference

Continue Reading →

News

Loncar introduces China BioPharma Index

LCHINA is the first and only stock market index available to the public that follows China’s biopharma industry from both its regional and U.S. listed perspective. ...

20 March 2018 News Biopharma | China

Continue Reading →

AeroGo

Integrated Product Development by PharmaLex

It’s All About Stem Cells

Covid 19

Current Edition

China sees huge bounce in pharma rankings ahead of hybrid CPhI & P-MEC China

Biotech in China: Maximising the Global Opportunity

WuXi STA first CDMO to support the approval of an innovative drug in China through the “MAH” pilot

Healios receives rights to develop and commercialize additional indications and Athersys receives $20 million in license fees, plus potential milestones payments and royalties

China’s domestic pharma industry driving huge machinery influx at P-MEC China

Internationalisation and regulatory reform driving growth and investment at CPhI China

China eliminates import duties on 28 Indian medicines

6th DPI Dry Powder Technology China Technology Conference

Loncar introduces China BioPharma Index

International Pharmaceutical Industry